Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of autologous adipose-derived neural progenitor stem cells in neuropathic pain
jRCTb070250113Recruiting
- Start
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in Neuralgia. Primary endpoint: Primary safety assessment shortly after infusion. Started Dec 2025; status: recruiting.
02
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCTb070250113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb070250113.